Nabulsi Azmi 4
4 · Phathom Pharmaceuticals, Inc. · Filed May 20, 2022
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Award
Common Stock
2022-05-19+12,000→ 33,378 total
Holdings
- 843.42(indirect: By 401(k))
Common Stock
- 785,700(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents restricted stock units ("RSUs") granted on May 19, 2022. One third (1/3) of the total number of RSUs granted vest on November 19, 2022, May 19, 2023 and November 19, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.